FS KKR Capital Corp announces $150 million preferred stock sale to KKR unit

FS KKR Capital Corp entered into a $150 million purchase agreement for newly issued cumulative convertible perpetual preferred stock, with closing contingent on a third-party tender offer for up to $150 million of its common stock and HSR waiting-period expiration. The company also reported Q1 2026 EPS of $0.41 versus $0.44 expected and revenue of $304 million versus $316.78 million expected, underscoring softer operating performance despite a 18.65% dividend yield and 13 straight years of dividend payments. The stock traded at $10.80, down nearly 38% over the past year.

Analysis

This is less a routine capital raise than a signal that FSK is trying to stabilize its liability side before the next portfolio mark cycle hits. A convertible preferred funded by a sponsor-aligned buyer can buy time, but it also tells you the common equity is being managed around, not into, by sophisticated capital that likely sees better recovery optionality in the credit book than in the common. That dynamic is usually a headwind for the stock in the next 1-3 months because the market tends to price in dilution, governance overhang, and a lower probability of a near-term rerating.

The bigger second-order effect is on financing pressure across the direct lending complex. If one of the better-known BDC platforms is effectively monetizing preferred capital while a related party simultaneously seeks common stock exposure through a tender, peers with similar non-accrual risk may face tighter funding optics and wider discounts to NAV. That can spill into the broader income space: higher-yield BDCs, CLO equity, and leveraged loan proxies may all trade more defensively if investors start demanding a larger cushion for credit marks and dividend durability.

The contrarian read is that the preferred structure may be economically smarter than the common market assumes. If credit conditions stabilize, preferred capital can reduce refinancing risk without forcing a punitive common equity issuance, and the sponsor’s willingness to commit fresh money may imply the underlying asset base is not as impaired as the recent earnings miss suggests. The key variable is not the headline yield; it is whether NAV erosion and non-accruals have peaked over the next 2 quarters. If those metrics inflect, the stock can rebound sharply from depressed levels, but until then the common remains a value trap risk rather than a clean income play.

Key Decisions for Investors

• Short FSK common for 1-3 months into the preferred closing window; thesis is dilution/overhang plus weak earnings momentum, with downside toward a discount-to-NAV reset. Cover if NAV and non-accrual disclosures improve materially next quarter.
• Pair trade: long KKR / short FSK over 4-8 weeks. KKR should benefit from sponsor credibility and fee-income resilience while FSK absorbs the market’s skepticism around BDC credit quality and capital structure complexity.
• Buy downside protection on FSK via put spreads 1-2 quarters out. Risk/reward favors defined-risk bearish exposure because the stock’s high headline yield can mask a faster de-rating if asset quality worsens.
• Relative-value long/short within income credit: short higher-beta BDCs against long lower-leverage peers if the sector weakens further. Use FSK as the short leg if loan spreads widen and investors punish funding uncertainty.
• Contrarian long only after confirmation: if Q2/Q3 shows stabilized NAV and fewer non-accruals, consider a tactical long in FSK common for a 10-15% bounce. Without that inflection, the yield is not enough compensation for equity subordination.